LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article ; Online: Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion.

    Zandberg, Wesley F / Kumarasamy, Jayakanthan / Pinto, B Mario / Vocadlo, David J

    The Journal of biological chemistry

    2012  Volume 287, Issue 47, Page(s) 40021–40030

    Abstract: Sialyl-Lewis X (sLe(X)) is a tetrasaccharide that serves as a ligand for the set of cell adhesion proteins known as selectins. This interaction enables adhesion of leukocytes and cancer cells to endothelial cells within capillaries, resulting in their ... ...

    Abstract Sialyl-Lewis X (sLe(X)) is a tetrasaccharide that serves as a ligand for the set of cell adhesion proteins known as selectins. This interaction enables adhesion of leukocytes and cancer cells to endothelial cells within capillaries, resulting in their extravasation into tissues. The last step in sLe(X) biosynthesis is the α1,3-fucosyltrasferase (FUT)-catalyzed transfer of an L-fucose residue to carbohydrate acceptors. Impairing FUT activity compromises leukocyte homing to sites of inflammation and renders cancer cells less malignant. Inhibition of FUTs is, consequently, of great interest, but efforts to generate glycosyltransferase inhibitors, including FUT inhibitors, has proven challenging. Here we describe a metabolic engineering strategy to inhibit the biosynthesis of sLe(X) in cancer cells using peracetylated 5-thio-L-fucose (5T-Fuc). We show that 5T-Fuc is taken up by cancer cells and then converted into a sugar nucleotide analog, GDP-5T-Fuc, that blocks FUT activity and limits sLe(X) presentation on HepG2 cells with an EC(50) in the low micromolar range. GDP-5T-Fuc itself does not get transferred by either FUT3 or FUT7 at a measurable rate. We further demonstrate that treatment of cells with 5T-Fuc impaired their adhesive properties to immobilized adhesion molecules and human endothelial cells. 5T-Fuc, therefore, is a useful probe that can be used to modulate sLe(X) levels in cells to evaluate the consequences of inhibiting FUT-mediated sLe(X) formation. These data also reveal the utility of using sugar analogues that lead to formation of donor substrate analogues within cells as a general approach to blocking glycosyltransferases in cells.
    MeSH term(s) Animals ; CHO Cells ; Cell Adhesion/drug effects ; Cricetinae ; Cricetulus ; Endothelial Cells/cytology ; Endothelial Cells/metabolism ; Enzyme Inhibitors/pharmacology ; Fucose/analogs & derivatives ; Fucose/pharmacology ; Fucosyltransferases/antagonists & inhibitors ; Fucosyltransferases/metabolism ; Glycosylation/drug effects ; Hep G2 Cells ; Humans ; Metabolic Engineering/methods ; Oligosaccharides/biosynthesis ; Selectins/metabolism ; Sialyl Lewis X Antigen
    Chemical Substances 5-thiofucose ; Enzyme Inhibitors ; Oligosaccharides ; Selectins ; Sialyl Lewis X Antigen ; Fucose (28RYY2IV3F) ; FUT7 protein, human (EC 2.4.1.-) ; Fucosyltransferases (EC 2.4.1.-) ; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase (EC 2.4.1.65)
    Language English
    Publishing date 2012-09-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.M112.403568
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Capillary zone electrophoresis method for the separation of glucosidase inhibitors in extracts of Salacia reticulata, a plant used in ayurvedic treatments of type-2 diabetes.

    Zandberg, Wesley F / Mohan, Sankar / Kumarasamy, Jayakanthan / Pinto, B Mario

    Analytical chemistry

    2010  Volume 82, Issue 12, Page(s) 5323–5330

    Abstract: A simple and reproducible capillary-zone electrophoresis (CZE) method was developed for the separation and quantitation of sulfonium-ion-containing compounds isolated from plants of the Salacia genus which are traditionally used in Ayurvedic medicine for ...

    Abstract A simple and reproducible capillary-zone electrophoresis (CZE) method was developed for the separation and quantitation of sulfonium-ion-containing compounds isolated from plants of the Salacia genus which are traditionally used in Ayurvedic medicine for the treatment of type-2 diabetes. The method sufficiently resolved four different compounds with confirmed glucosidase inhibitory activity, namely, salacinol, ponkoranol, kotalanol and de-O-sulfonated kotalanol. Separation could be achieved in less than 9 min, and calibration curves showed good linearity. Detection limits were determined to be in the low mug/mL range. This method was used to demonstrate that de-O-sulfonated kotalanol isolated from natural sources has identical ionic mobility to a synthetic standard. Furthermore, new extraction conditions were developed by which the zwitterionic compounds (salacinol, ponkoranol, and kotalanol) could be separated from de-O-sulfonated kotalanol in a single solid-phase extraction (SPE) procedure. The extraction gave reproducibly high recoveries and was used to process four commercial Salacia extracts for CZE analysis to reduce the complexity of resulting electropherograms and to facilitate the detection of the four inhibitors in question. De-O-sulfonated kotalanol was detected in two of four Salacia samples while ponkoranol was present in all four. A comparison of all samples tested demonstrated that they had remarkably similar patterns of peaks, suggesting that this CZE method may be useful in the chemical fingerprinting of Salacia-containing products.
    MeSH term(s) Calibration ; Electrophoresis, Capillary/economics ; Electrophoresis, Capillary/methods ; Enzyme Inhibitors/isolation & purification ; Glucosidases/antagonists & inhibitors ; Limit of Detection ; Salacia/chemistry ; Sulfonium Compounds/isolation & purification
    Chemical Substances Enzyme Inhibitors ; Sulfonium Compounds ; Glucosidases (EC 3.2.1.-)
    Language English
    Publishing date 2010-06-15
    Publishing country United States
    Document type Evaluation Studies ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1508-8
    ISSN 1520-6882 ; 0003-2700
    ISSN (online) 1520-6882
    ISSN 0003-2700
    DOI 10.1021/ac100843y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS.

    Kandasamy, Pachamuthu / Liu, Yuanjing / Aduda, Vincent / Akare, Sandheep / Alam, Rowshon / Andreucci, Amy / Boulay, David / Bowman, Keith / Byrne, Michael / Cannon, Megan / Chivatakarn, Onanong / Shelke, Juili Dilip / Iwamoto, Naoki / Kawamoto, Tomomi / Kumarasamy, Jayakanthan / Lamore, Sarah / Lemaitre, Muriel / Lin, Xuena / Longo, Kenneth /
    Looby, Richard / Marappan, Subramanian / Metterville, Jake / Mohapatra, Susovan / Newman, Bridget / Paik, Ik-Hyeon / Patil, Saurabh / Purcell-Estabrook, Erin / Shimizu, Mamoru / Shum, Pochi / Standley, Stephany / Taborn, Kris / Tripathi, Snehlata / Yang, Hailin / Yin, Yuan / Zhao, Xiansi / Dale, Elena / Vargeese, Chandra

    Nucleic acids research

    2022  Volume 50, Issue 10, Page(s) 5401–5423

    Abstract: Attaining sufficient tissue exposure at the site of action to achieve the desired pharmacodynamic effect on a target is an important determinant for any drug discovery program, and this can be particularly challenging for oligonucleotides in deep tissues ...

    Abstract Attaining sufficient tissue exposure at the site of action to achieve the desired pharmacodynamic effect on a target is an important determinant for any drug discovery program, and this can be particularly challenging for oligonucleotides in deep tissues of the CNS. Herein, we report the synthesis and impact of stereopure phosphoryl guanidine-containing backbone linkages (PN linkages) to oligonucleotides acting through an RNase H-mediated mechanism, using Malat1 and C9orf72 as benchmarks. We found that the incorporation of various types of PN linkages to a stereopure oligonucleotide backbone can increase potency of silencing in cultured neurons under free-uptake conditions 10-fold compared with similarly modified stereopure phosphorothioate (PS) and phosphodiester (PO)-based molecules. One of these backbone types, called PN-1, also yielded profound silencing benefits throughout the mouse brain and spinal cord at low doses, improving both the potency and durability of response, especially in difficult to reach brain tissues. Given these benefits in preclinical models, the incorporation of PN linkages into stereopure oligonucleotides with chimeric backbone modifications has the potential to render regions of the brain beyond the spinal cord more accessible to oligonucleotides and, consequently, may also expand the scope of neurological indications amenable to oligonucleotide therapeutics.
    MeSH term(s) Animals ; Cells, Cultured ; Central Nervous System ; Guanidine/chemistry ; Mice ; Neurons/drug effects ; Oligonucleotides, Antisense/chemistry ; Oligonucleotides, Antisense/pharmacology ; Phosphorothioate Oligonucleotides ; Ribonuclease H/metabolism
    Chemical Substances Oligonucleotides, Antisense ; Phosphorothioate Oligonucleotides ; Ribonuclease H (EC 3.1.26.4) ; Guanidine (JU58VJ6Y3B)
    Language English
    Publishing date 2022-01-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 186809-3
    ISSN 1362-4962 ; 1362-4954 ; 0301-5610 ; 0305-1048
    ISSN (online) 1362-4962 ; 1362-4954
    ISSN 0301-5610 ; 0305-1048
    DOI 10.1093/nar/gkac037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Endogenous ADAR-mediated RNA editing in non-human primates using stereopure chemically modified oligonucleotides.

    Monian, Prashant / Shivalila, Chikdu / Lu, Genliang / Shimizu, Mamoru / Boulay, David / Bussow, Karley / Byrne, Michael / Bezigian, Adam / Chatterjee, Arindom / Chew, David / Desai, Jigar / Favaloro, Frank / Godfrey, Jack / Hoss, Andrew / Iwamoto, Naoki / Kawamoto, Tomomi / Kumarasamy, Jayakanthan / Lamattina, Anthony / Lindsey, Amber /
    Liu, Fangjun / Looby, Richard / Marappan, Subramanian / Metterville, Jake / Murphy, Ronelle / Rossi, Jeff / Pu, Tom / Bhattarai, Bijay / Standley, Stephany / Tripathi, Snehlata / Yang, Hailin / Yin, Yuan / Yu, Hui / Zhou, Cong / Apponi, Luciano H / Kandasamy, Pachamuthu / Vargeese, Chandra

    Nature biotechnology

    2022  Volume 40, Issue 7, Page(s) 1093–1102

    Abstract: Technologies that recruit and direct the activity of endogenous RNA-editing enzymes to specific cellular RNAs have therapeutic potential, but translating them from cell culture into animal models has been challenging. Here we describe short, chemically ... ...

    Abstract Technologies that recruit and direct the activity of endogenous RNA-editing enzymes to specific cellular RNAs have therapeutic potential, but translating them from cell culture into animal models has been challenging. Here we describe short, chemically modified oligonucleotides called AIMers that direct efficient and specific A-to-I editing of endogenous transcripts by endogenous adenosine deaminases acting on RNA (ADAR) enzymes, including the ubiquitously and constitutively expressed ADAR1 p110 isoform. We show that fully chemically modified AIMers with chimeric backbones containing stereopure phosphorothioate and nitrogen-containing linkages based on phosphoryl guanidine enhanced potency and editing efficiency 100-fold compared with those with uniformly phosphorothioate-modified backbones in vitro. In vivo, AIMers targeted to hepatocytes with N-acetylgalactosamine achieve up to 50% editing with no bystander editing of the endogenous ACTB transcript in non-human primate liver, with editing persisting for at least one month. These results support further investigation of the therapeutic potential of stereopure AIMers.
    MeSH term(s) Animals ; Oligonucleotides ; Primates/genetics ; Primates/metabolism ; RNA ; RNA Editing/genetics ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism
    Chemical Substances Oligonucleotides ; RNA-Binding Proteins ; RNA (63231-63-0)
    Language English
    Publishing date 2022-03-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1311932-1
    ISSN 1546-1696 ; 1087-0156
    ISSN (online) 1546-1696
    ISSN 1087-0156
    DOI 10.1038/s41587-022-01225-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: 5-thiomannosides block the biosynthesis of dolichol-linked oligosaccharides and mimic class I congenital disorders of glycosylation.

    Zandberg, Wesley F / Gao, Ningguo / Kumarasamy, Jayakanthan / Lehrman, Mark A / Seidah, Nabil G / Pinto, B Mario

    Chembiochem : a European journal of chemical biology

    2012  Volume 13, Issue 3, Page(s) 392–401

    Abstract: In a cell-based assay for novel inhibitors, we have discovered that two glycosides of 5-thiomannose, each containing an interglycosidic nitrogen atom, prevented the correct zymogen processing of the prohormone proopiomelanocortinin (POMC) and the ... ...

    Abstract In a cell-based assay for novel inhibitors, we have discovered that two glycosides of 5-thiomannose, each containing an interglycosidic nitrogen atom, prevented the correct zymogen processing of the prohormone proopiomelanocortinin (POMC) and the transcription factor sterol-regulatory element-binding protein-2 (SREBP-2) in mouse pituitary cells and Chinese hamster ovary (CHO) cells, respectively. In the case of SREBP-2, these effects were correlated with the altered N-linked glycosylation of subtilisin/kexin-like isozyme-1 (SKI-1), the protease responsible for SREBP-2 processing under sterol-limiting conditions. Further examination of the effects of these compounds in CHO cells showed that they cause extensive protein hypoglycosylation in a manner similar to type I congenital disorders of glycosylation (CDGs) since the remaining N-glycans in treated cells were complete (normal) structures. The under-glycosylation of glycoproteins in 5-thiomannoside-treated cells is now shown to be caused by the compromised biosynthesis of the dolichol-linked oligosaccharide (DLO) N-glycosylation donor, although the nucleotide sugars required for the synthesis of DLOs were neither reduced under these conditions, nor were their effects reversed upon the addition of exogenous mannose. Analysis of DLO intermediates by fluorophore-assisted carbohydrate electrophoresis demonstrated that 5-thiomannose-containing glycosides block DLO biosynthesis most likely at a stage prior to the GlcNAc(2) Man(3) intermediate, on the cytosolic face of the endoplasmic reticulum.
    MeSH term(s) Animals ; CHO Cells ; Cells, Cultured ; Congenital Disorders of Glycosylation/metabolism ; Congenital Disorders of Glycosylation/prevention & control ; Cricetinae ; Disease Models, Animal ; Dolichols/antagonists & inhibitors ; Dolichols/biosynthesis ; Dolichols/chemistry ; Mannose/analogs & derivatives ; Mannose/chemistry ; Mannose/pharmacology ; Mice ; Oligosaccharides/antagonists & inhibitors ; Oligosaccharides/biosynthesis ; Oligosaccharides/chemistry
    Chemical Substances Dolichols ; Oligosaccharides ; Mannose (PHA4727WTP)
    Language English
    Publishing date 2012-01-19
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2020469-3
    ISSN 1439-7633 ; 1439-4227
    ISSN (online) 1439-7633
    ISSN 1439-4227
    DOI 10.1002/cbic.201100647
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.

    Kandasamy, Pachamuthu / McClorey, Graham / Shimizu, Mamoru / Kothari, Nayantara / Alam, Rowshon / Iwamoto, Naoki / Kumarasamy, Jayakanthan / Bommineni, Gopal R / Bezigian, Adam / Chivatakarn, Onanong / Butler, David C D / Byrne, Michael / Chwalenia, Katarzyna / Davies, Kay E / Desai, Jigar / Shelke, Juili Dilip / Durbin, Ann F / Ellerington, Ruth / Edwards, Ben /
    Godfrey, Jack / Hoss, Andrew / Liu, Fangjun / Longo, Kenneth / Lu, Genliang / Marappan, Subramanian / Oieni, Jacopo / Paik, Ik-Hyeon / Estabrook, Erin Purcell / Shivalila, Chikdu / Tischbein, Maeve / Kawamoto, Tomomi / Rinaldi, Carlo / Rajão-Saraiva, Joana / Tripathi, Snehlata / Yang, Hailin / Yin, Yuan / Zhao, Xiansi / Zhou, Cong / Zhang, Jason / Apponi, Luciano / Wood, Matthew J A / Vargeese, Chandra

    Nucleic acids research

    2022  Volume 50, Issue 10, Page(s) 5443–5466

    Abstract: Although recent regulatory approval of splice-switching oligonucleotides (SSOs) for the treatment of neuromuscular disease such as Duchenne muscular dystrophy has been an advance for the splice-switching field, current SSO chemistries have shown limited ... ...

    Abstract Although recent regulatory approval of splice-switching oligonucleotides (SSOs) for the treatment of neuromuscular disease such as Duchenne muscular dystrophy has been an advance for the splice-switching field, current SSO chemistries have shown limited clinical benefit due to poor pharmacology. To overcome limitations of existing technologies, we engineered chimeric stereopure oligonucleotides with phosphorothioate (PS) and phosphoryl guanidine-containing (PN) backbones. We demonstrate that these chimeric stereopure oligonucleotides have markedly improved pharmacology and efficacy compared with PS-modified oligonucleotides, preventing premature death and improving median survival from 49 days to at least 280 days in a dystrophic mouse model with an aggressive phenotype. These data demonstrate that chemical optimization alone can profoundly impact oligonucleotide pharmacology and highlight the potential for continued innovation around the oligonucleotide backbone. More specifically, we conclude that chimeric stereopure oligonucleotides are a promising splice-switching modality with potential for the treatment of neuromuscular and other genetic diseases impacting difficult to reach tissues such as the skeletal muscle and heart.
    MeSH term(s) Animals ; Exons ; Mice ; Muscle, Skeletal ; Muscular Dystrophy, Duchenne/drug therapy ; Muscular Dystrophy, Duchenne/therapy ; Oligonucleotides, Antisense/chemistry ; Oligonucleotides, Antisense/genetics ; Oligonucleotides, Antisense/pharmacology ; Phosphorothioate Oligonucleotides/chemistry ; Phosphorothioate Oligonucleotides/pharmacology ; RNA Splicing/drug effects
    Chemical Substances Oligonucleotides, Antisense ; Phosphorothioate Oligonucleotides
    Language English
    Publishing date 2022-01-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 186809-3
    ISSN 1362-4962 ; 1362-4954 ; 0301-5610 ; 0305-1048
    ISSN (online) 1362-4962 ; 1362-4954
    ISSN 0301-5610 ; 0305-1048
    DOI 10.1093/nar/gkac018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase.

    Jones, Kyra / Sim, Lyann / Mohan, Sankar / Kumarasamy, Jayakanthan / Liu, Hui / Avery, Stephen / Naim, Hassan Y / Quezada-Calvillo, Roberto / Nichols, Buford L / Pinto, B Mario / Rose, David R

    Bioorganic & medicinal chemistry

    2011  Volume 19, Issue 13, Page(s) 3929–3934

    Abstract: Inhibition of intestinal α-glucosidases and pancreatic α-amylases is an approach to controlling blood glucose and serum insulin levels in individuals with Type II diabetes. The two human intestinal glucosidases are maltase-glucoamylase and sucrase- ... ...

    Abstract Inhibition of intestinal α-glucosidases and pancreatic α-amylases is an approach to controlling blood glucose and serum insulin levels in individuals with Type II diabetes. The two human intestinal glucosidases are maltase-glucoamylase and sucrase-isomaltase. Each incorporates two family 31 glycoside hydrolases responsible for the final step of starch hydrolysis. Here we compare the inhibition profiles of the individual N- and C-terminal catalytic subunits of both glucosidases by clinical glucosidase inhibitors, acarbose and miglitol, and newly discovered glucosidase inhibitors from an Ayurvedic remedy used for the treatment of Type II diabetes. We show that features of the compounds introduce selectivity towards the subunits. Together with structural data, the results enhance the understanding of the role of each catalytic subunit in starch digestion, helping to guide the development of new compounds with subunit specific antidiabetic activity. The results may also have relevance to other metabolic diseases such as obesity and cardiovascular disease.
    MeSH term(s) 1-Deoxynojirimycin/analogs & derivatives ; 1-Deoxynojirimycin/chemistry ; 1-Deoxynojirimycin/pharmacology ; Acarbose/chemistry ; Acarbose/pharmacology ; Catalytic Domain ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Glycoside Hydrolase Inhibitors ; Kinetics ; Monosaccharides/chemistry ; Selenium Compounds/chemistry ; Selenium Compounds/pharmacology ; Starch/metabolism ; Sucrase-Isomaltase Complex/antagonists & inhibitors ; Sucrase-Isomaltase Complex/metabolism ; Sugar Alcohols/chemistry ; Sugar Alcohols/pharmacology ; Sulfates/chemistry ; Sulfates/pharmacology ; alpha-Glucosidases/metabolism
    Chemical Substances Enzyme Inhibitors ; Glycoside Hydrolase Inhibitors ; Kotalanol ; Monosaccharides ; Selenium Compounds ; Sugar Alcohols ; Sulfates ; blintol ; salacinol ; miglitol (0V5436JAQW) ; 1-Deoxynojirimycin (19130-96-2) ; Starch (9005-25-8) ; Sucrase-Isomaltase Complex (EC 3.2.1.-) ; alpha-Glucosidases (EC 3.2.1.20) ; Acarbose (T58MSI464G)
    Language English
    Publishing date 2011-07-01
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2011.05.033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase

    Jones, Kyra / Sim, Lyann / Mohan, Sankar / Kumarasamy, Jayakanthan / Liu, Hui / Avery, Stephen / Naim, Hassan Y / Quezada-Calvillo, Roberto / Nichols, Buford L / Mario Pinto, B / Rose, David R

    Bioorganic & medicinal chemistry. 2011 July 1, v. 19, no. 13

    2011  

    Abstract: Inhibition of intestinal α-glucosidases and pancreatic α-amylases is an approach to controlling blood glucose and serum insulin levels in individuals with Type II diabetes. The two human intestinal glucosidases are maltase-glucoamylase and sucrase- ... ...

    Abstract Inhibition of intestinal α-glucosidases and pancreatic α-amylases is an approach to controlling blood glucose and serum insulin levels in individuals with Type II diabetes. The two human intestinal glucosidases are maltase-glucoamylase and sucrase-isomaltase. Each incorporates two family 31 glycoside hydrolases responsible for the final step of starch hydrolysis. Here we compare the inhibition profiles of the individual N- and C-terminal catalytic subunits of both glucosidases by clinical glucosidase inhibitors, acarbose and miglitol, and newly discovered glucosidase inhibitors from an Ayurvedic remedy used for the treatment of Type II diabetes. We show that features of the compounds introduce selectivity towards the subunits. Together with structural data, the results enhance the understanding of the role of each catalytic subunit in starch digestion, helping to guide the development of new compounds with subunit specific antidiabetic activity. The results may also have relevance to other metabolic diseases such as obesity and cardiovascular disease.
    Keywords acarbose ; alpha-amylase ; alpha-glucosidase ; blood glucose ; cardiovascular diseases ; digestion ; glycosides ; humans ; hydrolysis ; insulin ; noninsulin-dependent diabetes mellitus ; obesity ; protein subunits ; starch ; sucrose alpha-glucosidase
    Language English
    Dates of publication 2011-0701
    Size p. 3929-3934.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2011.05.033
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article: Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase

    Jones, Kyra / Sim, Lyann / Mohan, Sankar / Kumarasamy, Jayakanthan / Liu, Hui / Avery, Stephen / Naim, Hassan Y. / Quezada-Calvillo, Roberto / Nichols, Buford L. / Mario Pinto, B. / Rose, David R.

    Bioorganic & medicinal chemistry

    Volume v. 19,, Issue no. 1

    Abstract: Inhibition of intestinal α-glucosidases and pancreatic α-amylases is an approach to controlling blood glucose and serum insulin levels in individuals with Type II diabetes. The two human intestinal glucosidases are maltase-glucoamylase and sucrase- ... ...

    Abstract Inhibition of intestinal α-glucosidases and pancreatic α-amylases is an approach to controlling blood glucose and serum insulin levels in individuals with Type II diabetes. The two human intestinal glucosidases are maltase-glucoamylase and sucrase-isomaltase. Each incorporates two family 31 glycoside hydrolases responsible for the final step of starch hydrolysis. Here we compare the inhibition profiles of the individual N- and C-terminal catalytic subunits of both glucosidases by clinical glucosidase inhibitors, acarbose and miglitol, and newly discovered glucosidase inhibitors from an Ayurvedic remedy used for the treatment of Type II diabetes. We show that features of the compounds introduce selectivity towards the subunits. Together with structural data, the results enhance the understanding of the role of each catalytic subunit in starch digestion, helping to guide the development of new compounds with subunit specific antidiabetic activity. The results may also have relevance to other metabolic diseases such as obesity and cardiovascular disease.
    Keywords blood glucose ; insulin ; cardiovascular diseases ; obesity ; acarbose ; hydrolysis ; humans ; starch ; alpha-glucosidase ; noninsulin-dependent diabetes mellitus ; glycosides ; digestion ; protein subunits ; sucrose alpha-glucosidase ; alpha-amylase
    Language English
    Document type Article
    ISSN 0968-0896
    Database AGRIS - International Information System for the Agricultural Sciences and Technology

    More links

    Kategorien

To top